The signal peptide missense variant in cancer-brake gene CTLA4 was associated with lower risk and poor prognosis in breast carcinoma among Egyptian women, might have prognostic as well diagnostic impact in breast cancer [9]. The gene discussed is CTLA4; the disease is breast carcinoma.